Submitted by Anonymous (not verified) on 23 September 2024 - 14:59
Human medicines European public assessment report (EPAR): Braftovi, encorafenib, Date of authorisation: 19/09/2018, Revision: 14, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Braftovi, encorafenib, Date of authorisation: 19/09/2018, Revision: 14, Status: Authorised